Malignant neoplasm of renal pelvis
Chapter 2:Neoplasms
ICD-10 C65 is a billable code used to indicate a diagnosis of malignant neoplasm of renal pelvis.
Malignant neoplasm of the renal pelvis refers to cancer that originates in the renal pelvis, the area of the kidney where urine collects before moving to the ureter. This type of cancer is often associated with transitional cell carcinoma, which arises from the urothelium lining the renal pelvis. Risk factors include smoking, exposure to certain chemicals, and chronic urinary tract infections. Symptoms may include hematuria (blood in urine), flank pain, and urinary obstruction. Diagnosis typically involves imaging studies such as CT scans or MRIs, followed by biopsy for histological confirmation. Staging of renal pelvis cancer is crucial for determining treatment options and prognosis, often classified using the TNM system (Tumor, Node, Metastasis). Surgical management may include nephroureterectomy, where the affected kidney and ureter are removed, or less invasive procedures like endoscopic resection, depending on the tumor's size and location. Adjuvant therapies, including chemotherapy or immunotherapy, may also be considered based on the stage of the disease.
Detailed operative reports, imaging studies, and pathology results.
Diagnosis and management of renal pelvis tumors, surgical interventions, and follow-up care.
Ensure accurate staging and documentation of any adjuvant therapies.
Comprehensive treatment plans, chemotherapy regimens, and response assessments.
Management of advanced renal pelvis cancer, including systemic therapies.
Documenting the rationale for treatment choices and patient responses.
Used for surgical management of renal pelvis tumors.
Operative report detailing the procedure and findings.
Urology specialists should ensure accurate coding of the surgical approach.
Common symptoms include hematuria, flank pain, and urinary obstruction. Patients may also experience changes in urinary habits.
Diagnosis typically involves imaging studies such as CT or MRI, followed by biopsy to confirm malignancy.
The TNM system is commonly used, which assesses tumor size, lymph node involvement, and metastasis.
Treatment may include surgical resection, chemotherapy, and immunotherapy, depending on the stage of the cancer.
